Treprostinil (Tyvaso)

About United Therapeutics

United Therapeutics Corporation is a biotechnology company dedicated to developing life-saving medicines for patients with rare diseases, particularly pulmonary arterial hypertension. Founded in 1996 by Dr. Martine Rothblatt, the company has successfully commercialized multiple breakthrough therapies and continues to advance innovative treatment approaches including gene therapy and xenotransplantation. With a strong financial position and diversified product portfolio, United Therapeutics is well-positioned to maintain its leadership in rare disease therapeutics.

Therapeutic Areas